{"id":1003,"date":"2022-05-12T12:16:34","date_gmt":"2022-05-12T03:16:34","guid":{"rendered":"https:\/\/www.mypresto5.jp\/en\/?page_id=1003"},"modified":"2022-05-15T15:51:30","modified_gmt":"2022-05-15T06:51:30","slug":"license","status":"publish","type":"page","link":"https:\/\/www.mypresto5.jp\/en\/license\/","title":{"rendered":"License"},"content":{"rendered":"\n\n\n\n
\n

myPresto5 License<\/b><\/h4>\n

Japan Biological Informatics Consortium ( here after \u201cJBIC\u201d) has been developing a software suite in the Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis (2018-2021 and 2021-) from Japan Agency for Medical Research and Development (AMED) , the JBIC membership fee and personal activities of the developers. The software suite includes the following functions.<\/p>\n

\u30fbSimulation of biological systems including proteins, membrane and compounds.\u00a0
\u30fbProtein\/RNA-compound docking
\u30fbin silico drug screening, and etc.<\/p>\n

This software suite is called \u201cmyPresto5\u201d (Medicinally Yielding PRotein Engineering SimulaTOr version 5), and JBIC allows anyone to using myPresto5 under the GNU Lesser General Public License version 2.1 (LGPL-2.1) condition.<\/strong>
JBIC allows the JBIC members and the myPresto5 developers listed below the JBIC-member license including commercial use, modification, re-distribution, and etc.<\/strong><\/p>\n

\n

\u7279\u8a18\u4e8b\u9805\uff1amyPresto5\u958b\u767a\u8005
Notice : myPresto5 developers<\/p>\n

\u3053\u3053\u306b\u6319\u3052\u308b\u8005\u306fmyPresto\u958b\u767a\u8005\u3068\u3057\u3066JBIC\u4f1a\u54e1\u3068\u540c\u7b49\u306e\u30e9\u30a4\u30bb\u30f3\u30b9\u306e\u4e0b\u3067myPresto5\u3092\u5229\u7528\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002
JBIC allows the listed myPresto5 developers to use myPresto5 under the same condition of the License for JBIC members.<\/p>\n\n\n\n\n
\u4e2d\u6751 \u6625\u6728\uff08Nakamura, Haruki)
\u798f\u897f \u5feb\u6587\uff08Fukunishi, Yoshifumi)
\u771f\u4e0b \u5fe0\u5f70\uff08Mashimo, Tadaaki)
\u9ed2\u6fa4 \u9686\uff08Kurosawa, Takashi)
\u5ddd\u7aef \u731b\uff08Kawabata, Takeshi)
\u7b20\u539f \u6d69\u592a\uff08Kasahara, Kota)
Bhaskar Dasgupta
\u80a5\u5f8c \u9806\u4e00\uff08Higo, Junichi)
\u798f\u7530 \u80b2\u592b\uff08Fukuda, Ikuo\uff09
\u795e\u8c37 \u6210\u654f\uff08Kamiya, Narutoshi)
\u6749\u539f \u5d07\u61b2\uff08Sugihara, Takanori)
\u548c\u7530 \u5149\u4eba\uff08Wada, Mitsuhito)
\u91d1\u4e95 \u5343\u91cc\uff08Kanai, Chisato)
\u5409\u5ddd \u9054\u4e5f\uff08Yoshikawa, Tatsuya)<\/td>\n		\u6728\u5bfa \u8a54\u7d00\uff08Kidera, Akinori)
\u5bfa\u7530 \u900f\uff08Terada, Toru)
\u7aaa\u7530 \u8061\uff08Kubota, Satoru\uff09
\u6e21\u8fba \u5e78\u4e45\uff08Watanabe, Yukihisa S.)
\u4f0a\u5948 \u5eb7\u592b\uff08Ina, Yasuo)
\u91d1 \u5728\u5409\uff08Jae Gil, Kim\uff09
\u4e09\u4e0a \u7fa9\u660e\uff08Mikami, Yoshiaki)
\u6a4b \u7950\u4e00\uff08Hashi, Yuichi)
\u5dfd \u7406\u6075\uff08Tatsumi, Rie\uff09
\u68ee\u4e0a\u8ce2\u6cbb\uff08Morikami, Kenji)
\u4e2d\u4e95 \u5b5d\u5c1a\uff08Nakai, Takahisa)
\u91d1\u57ce \u73b2\uff08Kinjo, Akira)
\u6749\u539f \u88d5\u4ecb\uff08Sugihara, Yusuke)
\u4e2d\u6751 \u5bdb\u5247\uff08Nakamura, Hironori)
\u2015\u4ee5\u4e0a\u2015<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n		\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

myPresto5 License Japan Biological Informatics Consortium ( here after \u201cJBIC\u201d) has been developing a software suite in the Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis (2018-2021 and 2021-) from Japan Agency for Medical Research and Development (AMED) , the JBIC membership fee and personal activities of the developers. The software suite includes the following functions. \u30fbSimulation of biological systems including proteins, membrane and compounds.\u00a0\u30fbProtein\/RNA-compound docking\u30fbin silico drug screening, and etc. This software suite is called \u201cmyPresto5\u201d (Medicinally Yielding PRotein Engineering SimulaTOr version 5), and JBIC allows anyone to using myPresto5 under the GNU Lesser General Public License version 2.1 (LGPL-2.1) condition.JBIC…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"_links":{"self":[{"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/pages\/1003"}],"collection":[{"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/comments?post=1003"}],"version-history":[{"count":5,"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/pages\/1003\/revisions"}],"predecessor-version":[{"id":1038,"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/pages\/1003\/revisions\/1038"}],"wp:attachment":[{"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/media?parent=1003"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mypresto5.jp\/en\/wp-json\/wp\/v2\/tags?post=1003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}